We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Poolbeg Pharma Plc | LSE:POLB | London | Ordinary Share | GB00BKPG7Z60 | ORD 0.02P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| -0.05 | -0.40% | 12.60 | 2,944,802 | 12:32:08 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 12.40 | 12.80 | 12.65 | 12.30 | 12.65 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Coml Physical, Biologcl Resh | -3.93M | -0.0079 | -15.95 | 63.25M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 16:23:26 | O | 985,150 | 12.15 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 26/7/2024 | 18:59 | ALNC |  EARNINGS AND TRADING: Man Group profit rises; Petershill AUM increases |
| 26/7/2024 | 07:00 | UK RNS | Poolbeg Pharma PLC Voluntary Delisting from OTCQB Market |
| 10/7/2024 | 07:00 | UK RNS | Poolbeg Pharma PLC Notification of Major Holdings |
| 02/7/2024 | 07:00 | UK RNS | Poolbeg Pharma PLC Change of Registered Address |
| 17/6/2024 | 08:38 | UK RNS | Poolbeg Pharma PLC Result of AGM |
| 09/5/2024 | 07:00 | UK RNS | Poolbeg Pharma PLC Annual Report & AGM Notice |
| 01/5/2024 | 16:39 | ALNC | Poolbeg Pharma celebrates full patent approval for Immunomodulator II |
| 01/5/2024 | 07:00 | UK RNS | Poolbeg Pharma PLC Significant POLB 001 Patent Granted in USA |
| 30/4/2024 | 16:30 | ALNC | EARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV down |
| 30/4/2024 | 07:02 | UK RNS | Poolbeg Pharma PLC Appointment of Joint Broker |
Poolbeg Pharma (POLB) Share Charts1 Year Poolbeg Pharma Chart |
|
1 Month Poolbeg Pharma Chart |
Intraday Poolbeg Pharma Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 26/7/2024 | 18:34 | Poolbeg Pharma | 3,486 |
| 24/10/2022 | 16:20 | Polb | 1 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 2024-07-26 16:15:00 | 12.15 | 985,150 | 119,695.73 | O |
| 2024-07-26 15:23:27 | 12.47 | 4,228 | 527.34 | O |
| 2024-07-26 15:23:17 | 12.47 | 17,000 | 2,120.33 | O |
| 2024-07-26 15:19:56 | 12.79 | 157 | 20.08 | O |
| 2024-07-26 14:09:51 | 12.51 | 52,419 | 6,559.45 | O |
| Top Posts |
|---|
Posted at 26/7/2024 09:20 by Poolbeg Pharma Daily Update Poolbeg Pharma Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker POLB. The last closing price for Poolbeg Pharma was 12.65p.Poolbeg Pharma currently has 500,000,000 shares in issue. The market capitalisation of Poolbeg Pharma is £63,000,000. Poolbeg Pharma has a price to earnings ratio (PE ratio) of -15.95. This morning POLB shares opened at 12.65p |
Posted at 02/7/2024 12:38 by pogue peterr3I will spell it out as I feel you were listening to the wrong bits there. The lead asset of POLB is POLB001 and will be the first monetized. 2 pharmas are interested in it as their new very powerful cancer drugs have the side effect of cytokine storms. Cytokline storms mean that patients tie up hospital beds in cancer units thus reducing the amount of drugs that can be administered so huge incentive to find a drug that prevents them happening, like POLB001. Hugh incentive there for a phamra to partner with POLB if POLB001 works. Now as a stand alone drug POLB001 does the job all they have to do is prove it works whilst other drugs are in a patients system. The 2 pharmas have already given POLB the drugs, worth £millions, to run the trial and will pay for the trial as the market for their drug is 10s of $billions. We await the trial date how long do you think the pharmas are going to wait with a prize of that size? Now the other part you need to research is what normally happens in these situations ie a drug going to trial with another and what the trial contract normally says baring in mind that if it proves successful the value of POLB001 goes through the roof. Clue the contract has a section on that and I strongly suggest that is the reason for the delay as its a very important section.. Sorry if very direct but you have missed the point completely of what is happening and this board has so many halfwit derampers who avoid basic facts that I treat posters I dont know with suspicion. |
Posted at 01/7/2024 16:23 by peterrr3 I think you will be waiting a while. I figure announce income acquisition, talk it up over couple of months to try shift the share price, pass the hat around b4 Xmas shut down.Or no acquisition, need to fund a phase 2 to get pharma properly interested. Do it on the cheap in Turkey but still need to pass the hat around. |
Posted at 07/5/2024 22:47 by elrico Sicko, It's unjust to judge others by your own standards. I consistently reveal my sale/top slice a minimum of two trading days in advance if I possess a stated position. Additionally, not everyone can dedicate hundreds of hours each month; some have demanding careers, families, etc. Nevertheless, I do concur that whenever feasible, investors ought to DTOR, such as reviewing independent analyses. You might label these individuals as "cheerleaders" to fit your narrative. Relying on your analyses could have been risky with HVO and POLB, yet one thing is certain, you have been consistently inaccurate.I recall you singing the pump & dump song when POLB share price was c6p. Had anyone been put off by your constant trashing, they would have missed out on healthy gains. I do hope you are pleased with yourself. Instead of just highlighting investors' losses, why not provide some balance by sharing your own? As flawless as you may seem compared to Buffet and Munger, I'm fairly certain you've also had your fair share of failed investments. I know I have over the past 30+ years. Play nice! |
Posted at 07/5/2024 14:44 by sikhthetech Look at Nexn, no posts.Polb busy, Nexn quiet.. Look at the posts from 1gw's mates: Friends with 6 figures, hundreds of trades, chasing off anyone with a contrarian view... 70-90% down on majority of their shares. Rthm crashed from 590p to 100p based on the red flags I warned about. Trmr crashed from 850p to currently 150p based on the red flags I warned about. NANO crashed from 70p to 16p based on the events I warned about. STU bust etc etc No wonder they are bitter. Look at their own posts!! Look at how the same post was posted dozens of times to trash my thread in order to hide company/sector newsflow. Rthm share price went onto crash, 590p to 100p based on the red flags the same posters were trying to hide. football - 29 Nov 2018 - 19:25:23 - 9898 of 11054 RHYTHMONE - new Name, new just in case you missed it again in the header Football's own admission..to see off posters bashing (posting a contrarian view). Why? all views bull/bear should be welcome... football - 14 Nov 2010 - 23:55:37 - 30806 of 107028 BLINKX re-SEARCH (2009) <...> i have seen off grax this year with his bashing and chris2601 is next BARKBOO - 30 Oct 2012 - 09:25:38 - 23685 of 27952 Listen - I make on average 500-600 bets a day on horse racing indexes, a lot more on big meeting days. I know how to achieve an edge, I vary rarely lose! If that edge climbed to several 100% profit every day as opposed to several %, the betting patterns would show up, and the foul play finger could be pointed straight at me, I would pay the price! THE GANG WITH THEIR MULTIPLE IDS CAN CONTINUE TO LIVE IN NICE HOUSES. BARKBOO29 Jan '20 - 14:25 - 1007 of 1007 With today's news - I have a whole gang of friends with six figures waiting to attack a moody Tosca low volume sting back.... BARKBOO - 01 Nov 2018 - 07:02:48 - 7292 of 7798 "The family manage to have nice houses, cars, holidays and social lives - we have had two or three big pay days here, with the fourth on its way - it sounds to me like you traded your pot like the others on here..and like the rags, you done a bit of swirling! |
Posted at 20/3/2024 07:56 by burtond1 ??????????? RNS this for @PoolbegPharma Notice of Allowance for Significant POLB 001 Patent in United States"...I am excited by the potential of POLB 001 to positively impact global health..."#POLB CEO Jeremy Skillingtonhttps://w |
Posted at 11/3/2024 15:10 by sikhthetech Supernumerary,Polb is all talk, jam tomorrow. TLY announced yet another contract today... you must be even more dismayed than before... IIs increasing and now more contracts... Plus it's in Republic of Ireland!!. Which confirms you're clueless, given you believe TLY has only 1 customer... Republic of Ireland is NOT part of NHS or even the UK... Clueless. As to holding several shares. You mean like yours, 1gw and the blnx gang. Byot, down 95% Nexn, ex blnx, ex trmr, ex rthm (so many changes) down 80-90% depending on which iteration of name change you choose. Nano, down 60% etc etc Polb still around IPO share price after years of talking. HVO still below the 45p peak of years gone past and where the founder/Chairman dumped majority of his holding. That's quite an appalling history of failures for someone who portray themselves as well researched, isn't it?. :-) |
Posted at 15/2/2024 11:07 by 1gw parsons4 - well if we take CF's relatively recent linkedin post at face value (and I know some don't) about aiming to complete the IPO of POLB on Nasdaq later this year then I can understand his desire to get the share price up ahead of setting the price for that.If I were then to look at even more recent discussion of acquiring and commercialising rare/orphan disease drugs, I might start to think that there could be a plan to acquire or reverse in to an existing Nasdaq-quoted company that was low on cash but had some promising approved or late phase drugs, particularly if those drugs were in the oncology space that would fit with trials of POLB001 for immunotherapy-induce Whether IPO'ing directly as POLB, or raising cash following, or as part of, an acquisition/reverse, a high shareprice would be a lot more useful than a low shareprice in terms of minimising the dilution of existing shareholders. |
Posted at 15/2/2024 10:05 by lfdkmp Surprised nobody has commented on (from today's RNS) :"... with vesting conditional upon the weighted-average of the mid-market closing price of the ordinary shares in the Company being 17.945 pence or above over a period of fourteen calendar days (representing a c.85% premium to the share price at close of market on February 14, 2024)." Maybe an indication of management's expectations of share price in medium term? (as it stands today, not exactly a gimme ) |
Posted at 07/2/2024 18:54 by troutisout We have all seen the great rise in HVO over the last 7 months, starting with contract wins in late June and July, then the positive trading update at the end of July and of course, what was the start of Institutional buying.Before that POLB mirrored HVO quite closely, deviating a little every now and then and then one or the other adjusting back. POLB showed the way in late Summer/Autumn 2022 with HVO mirroring the moves several weeks later. Then HVO leapt ahead of POLB in the late Summer/Autumn 2023, but the news of the Amryt team joining propelled POLB back up there again in November. As we went into the Christmas period and the New Year HVO has hit the rocket boosters with more contract wins and a really good TU. POLB has dithered and dropped slightly. I don't think the relationship between the two has broken (although the II buying in HVO will have diluted the relationship where many of the holders of HVO also held POLB). So we wait to see if POLB catches up again, it certainly looks a few weeks behind but the correlation has been strong up to now.... POLB black, HVO Blue, HVO overlaid on POLB from the first day of POLB trading free stock charts from uk.advfn.com |
Posted at 26/1/2024 07:48 by troutisout Klosters whether you think I am besotted or not, I have been saying as much at HVO for 8 months and it has been backed up by II holdings in that period. Here at POLB there looks to be some large buying at times, so could well be some larger buyers, however after every rise the share price gets pulled back down and often before the volume of sells to justify any drops, the price is leading the selling, who quotes the prices? Who sells all the shares to buyers in a rise? Who needs to eventually balance their books?As for IIs they do buy at lower prices than retail because they have the clout to, if the order is large enough then you can put a limit buy in below the market and watch the share price migrate to that price and the order get filled before then moving back up again. Or do you believe this is a fair and even system? |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
